Jan 28 2010
Formatech continues its pledge to give back and make a difference in the
biotechnology and pharmaceutical community with its Fillanthropy
Program. Since the program’s inception, Formatech has donated $308K in
aseptic liquid fill and finish manufacturing services to companies
developing new drug therapies.
“We feel it is important
to do our part to help new therapies like these reach the patients in
need.”
Introduced in August 2009, Formatech’s Fillanthropy Program has awarded
fills to GeoVax Labs for their HIV/AIDS vaccine, KAI Pharmaceuticals for
their secondary hyperparathyroidism treatment and most recently to
ViroMed for their vaccine targeting breast cancer. “Each of us either
knows someone or has personally been touched by the impact of a chronic
disease,” said Indu Isaacs, CEO of Formatech. “We feel it is important
to do our part to help new therapies like these reach the patients in
need.”
As an established cGMP contract manufacturer with over 16 years of
service, Formatech understands its role in helping to fight disease. It
is within this spirit that the Fillanthropy Program was created. “At
Formatech, we envision a world where all companies with promising new
drug therapies have the opportunity to conduct a full clinical
development program,” said Jeffrey Bernard, Formatech’s Director of
Business Development.
Source: Formatech